^
Association details:
Evidence:
Evidence Level:
Sensitive: C4 – Case Studies
New
Title:

Third-line sunitinib treatment in a VHL-mutated metastatic intrahepatic cholangiocarcinoma: a case report and literature review

Excerpt:
We herein present a case of a 46-y-old Asian iCCA patient with multiple metastases in lung, bone, and liver...According to next- generation sequencing result of somatic Von Hippel-Lindau (VHL) gene mutation, the patient was administered third-line sunitinib and obtained a relatively longer survival of 9 months after taking sunitinib.
DOI:
https://doi.org/10.1080/15384047.2020.1769418